Cancer Institute Hospital of JFCR
Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval
New Treatment Effective In Up To 73% Of Multiple Myeloma Patients!
Car-T Therapy Ide-Cel For Multiple Myeloma Prolongs Patient Survival By 2-Fold!
There Is No Cure For Alzheimer's Disease And Death Usually Occurs Within Ten Years Of Diagnosis, So The Best Option Now Is To Prevent It Early.
New Study: Nmn Supplementation Activates Longevity Proteins To Reduce Stem Cell Senescence And Restore Mitochondrial Function
